Puma Biotechnology Inc (NASDAQ: PBYI) is -44.11% lower on its value in year-to-date trading and has touched a low of $2.22 and a high of $7.73 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PBYI stock was last observed hovering at around $2.99 in the last trading session, with the day’s loss setting it -0.57%.
Currently trading at $2.42, the stock is -16.90% and -11.43% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.54 million and changing -19.06% at the moment leaves the stock -38.64% off its SMA200. PBYI registered -36.32% loss for a year compared to 6-month loss of -40.90%. The firm has a 50-day simple moving average (SMA 50) of $2.7324 and a 200-day simple moving average (SMA200) of $3.94445.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -14.49% gain in the last 1 month and extending the period to 3 months gives it a -14.49%, and is -15.97% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.36% over the week and 8.85% over the month.
Puma Biotechnology Inc (PBYI) has around 185 employees, a market worth around $96.14M and $243.57M in sales. Current P/E ratio is 5.10 and Fwd P/E is 7.12. Profit margin for the company is 9.54%. Distance from 52-week low is 8.76% and -68.69% from its 52-week high. The company has generated returns on investments over the last 12 months (21.76%).
with sales reaching $52.5M over the same period.The EPS is expected to shrink by -33.33% this year, but quarterly earnings will post -4.97% year-over-year. Quarterly sales are estimated to shrink -27.29% in year-over-year returns.
Puma Biotechnology Inc (PBYI) Top Institutional Holders
137.0 institutions hold shares in Puma Biotechnology Inc (PBYI), with institutional investors hold 79.81% of the company’s shares. The shares outstanding are 47.65M, and float is at 35.19M with Short Float at 9.06%. Institutions hold 67.73% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 3.6 million shares valued at $11.73 million. The investor’s holdings represent 7.4684% of the PBYI Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 3.57 million shares valued at $11.65 million to account for 7.4141 of the shares outstanding. The other top investors are MILLENNIUM MANAGEMENT LLC which holds 3.16 million shares representing 6.5627% and valued at over $10.31 million, while FRAZIER LIFE SCIENCES MANAGEMENT, L.P. holds 6.3553 of the shares totaling 3.06 million with a market value of $9.98 million.
Puma Biotechnology Inc (PBYI) Insider Activity
The most recent transaction is an insider sale by MILLER MICHAEL PATRICK, the company’s Director. SEC filings show that MILLER MICHAEL PATRICK sold 23,358 shares of the company’s common stock on Aug 12 ’24 at a price of $3.49 per share for a total of $81466.0. Following the sale, the insider now owns 47000.0 shares.
Still, SEC filings show that on Jul 17 ’24, NOUGUES MAXIMO F (Chief Financial Officer) disposed off 4,156 shares at an average price of $3.70 for $15382.0. The insider now directly holds 162,522 shares of Puma Biotechnology Inc (PBYI).
